British Patient Capital
British Patient Capital is a UK government-backed investment programme within British Business Bank that provides long-term equity capital to UK technology and science growth companies through fund-of-funds and co-investment activity.
- Company typePrivate
- Founded2014
- HeadquartersSheffield, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What British Patient Capital does
British Patient Capital is an investment programme operated under British Business Bank plc, a public limited company wholly owned by HM Government. Headquartered in Sheffield with 11–50 employees, it provides long-term equity capital — so-called "patient capital" — to UK technology and science companies that require extended investment horizons to scale. Its core activity is fund-of-funds investing and co-investment alongside private venture and growth capital firms; recent disclosed activity includes a $26 million Series B co-investment in Iceotope Technologies, a precision liquid cooling business serving AI data centres.
The programme is delivered through a set of branded equity-finance vehicles, including the Patient Capital Funds sub-brand and the Long-term Investment for Technology and Science (LIFTS) programme, alongside adjacent British Business Bank offerings such as Angel Cofund, Future Fund: Breakthrough, Life Sciences Investment Programme, Managed Funds, Enterprise Capital Funds, and Growth Equity. Distribution is indirect: the entity does not sell products to end customers but participates in funding rounds as an LP or co-investor, leveraging the broader British Business Bank ecosystem (Finance Finder, Start Up Loans, regional investment funds) for origination and partner coordination.
As a government-owned development bank subsidiary, British Patient Capital's revenue mechanics are not publicly disclosed; its financial base derives from HM Government capital commitments, and its strategic mandate is set by the Government's Statement of Strategic Priorities and operationalised through British Business Bank's Corporate Strategy 2025–2030. Reported impact metrics at the parent level include £39bn in cumulative finance delivered, 250,000 expected jobs supported, and £43bn in expected GVA generated across all British Business Bank programmes.
British Patient Capital firmographics
Firmographics- Name
- British Patient Capital
- Legal name
- British Business Bank plc
- Website
- https://britishpatientcapital.co.uk
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- British Patient Capital is a UK government-backed investment programme within British Business Bank that provides long-term equity capital to UK technology and science growth companies through fund-of-funds and co-investment activity.
- Ownership category
- akta.pro rank
British Patient Capital industry classification
Industry- Product category
- Venture Capital / Development Finance
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259), Other Financial Vehicles (525990)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)
- akta.pro secondary industries
- Venture Capital Fund-of-Funds (FSANAGAC), Growth Equity Fund-of-Funds (FSANAGAE)
Keywords
Where British Patient Capital is headquartered
LocationHeadquarters
- HQ city
- Sheffield
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
British Patient Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels5 records
British Patient Capital product offering
Product offeringCore offering
British Patient Capital is the patient-capital investment arm of British Business Bank plc, deploying long-term equity capital from HM Government into UK venture and growth capital funds and directly into UK technology and science startups and growth-stage companies. It operates specific equity finance programmes (Patient Capital Funds, LIFTS, Future Fund: Breakthrough, Life Sciences Investment Programme, Growth Equity, Managed Funds Programme, National Security Strategic Investment Fund, and the Enterprise Capital Funds programme) that co-invest alongside private investors to bridge the long-horizon equity funding gap in the UK.
Product overview
British Patient Capital is a venture capital investment entity that provides long-term investment to UK technology companies. As an investment fund manager, it does not offer a traditional product portfolio in the sense of software or technology services. British Patient Capital participates in funding rounds for growth-stage technology companies, with investments spanning sectors including data center infrastructure (e.g., precision liquid cooling technology), fintech, and AI-enabled manufacturing. The entity operates as part of the British Business Bank group and focuses on patient capital deployment to support scaling of UK technology businesses.
Differentiator
Problem solved
Functional benefit
Brands
- Patient Capital Funds: Long-term equity investment programme focused on UK technology and science companies
Products and services
- Patient Capital Funds Long-term equity investment programme providing patient capital to UK technology and science companies through fund-of-funds and direct investment structures. Targeted at growth-stage UK businesses needing extended investment horizons to scale.
- Long-term Investment for Technology and Science (LIFTS) Equity finance programme providing long-term investment into UK technology and science growth companies, sitting within British Patient Capital's equity finance offerings.
- Future Fund: Breakthrough Equity finance programme providing patient capital to UK R&D-intensive breakthrough-technology companies that require long investment horizons.
- Life Sciences Investment Programme Equity finance programme investing long-term capital into UK life-sciences companies needing extended horizons to bring therapies and platforms to market.
- Growth Equity Growth-stage equity programme providing capital to scaling UK businesses beyond the early venture stage, supporting later-stage rounds.
- Managed Funds Programme Equity finance programme that allocates long-term capital to externally managed venture and growth capital funds investing in UK smaller businesses.
- National Security Strategic Investment Fund Equity finance programme providing patient capital to UK companies in technologies and sectors deemed of strategic national security importance.
- The Enterprise Capital Funds programme Equity finance programme that supports enterprise-capital fund managers, providing LP commitments to funds backing UK growth businesses.
Quantifiable outcome
- £39bn in finance delivered across UK economy
- +1 more outcomes
Companies that use British Patient Capital
Customer profileSegments1 record
Ideal customer profiles2 records
British Patient Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
British Patient Capital partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights3 records
British Patient Capital competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
British Patient Capital social profiles
Digital presenceBritish Patient Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
British Patient Capital leadership team
Management profileNumber of profiles
Profiles3 records
British Patient Capital subsidiaries and ownership
Company hierarchySubsidiaries1 record
British Patient Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
British Patient Capital M&A and investment
M&A and investmentM&A
Investments40 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about British Patient Capital
What does British Patient Capital do?
British Patient Capital is the patient-capital investment arm of British Business Bank plc, deploying long-term equity capital from HM Government into UK venture and growth capital funds and directly into UK technology and science startups and growth-stage companies. It operates specific equity finance programmes (Patient Capital Funds, LIFTS, Future Fund: Breakthrough, Life Sciences Investment Programme, Growth Equity, Managed Funds Programme, National Security Strategic Investment Fund, and the Enterprise Capital Funds programme) that co-invest alongside private investors to bridge the long-horizon equity funding gap in the UK.
Is British Patient Capital a public or private company?
British Patient Capital is a private company. It is classified as state government owned and is currently operating.
When was British Patient Capital founded?
British Patient Capital was founded in 2014. It employs 11 to 50 people.
Where is British Patient Capital based?
British Patient Capital is headquartered in Sheffield, United Kingdom, in the Europe region.
Does British Patient Capital have an API?
No public API is recorded for British Patient Capital.
What industry is British Patient Capital in?
British Patient Capital's product category is Venture Capital / Development Finance. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms, with a secondary code of FSANAGAC, Venture Capital Fund-of-Funds. Its NAICS code is 523940 and its SIC code is 6282.